Clinical Trial Update: A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease [Phase 2]

View source ↗

Summary

This document outlines a Phase 2 study of NEU-411 in companion diagnostic-positive individuals with early Parkinson's disease, plus an open-label extension. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• NEU-411

Snippet

Sponsor: Neuron23 Inc. | Conditions: Parkinson Disease, Parkinson | Phase 2 | Status: RECRUITING